Yigal Nochomovitz
Stock Analyst at Citigroup
(3.26)
# 1,026
Out of 4,948 analysts
308
Total ratings
43.85%
Success rate
2.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $33 | $19.53 | +68.97% | 3 | Aug 12, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $47 → $49 | $19.48 | +151.54% | 6 | Aug 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $20 → $21 | $5.51 | +281.13% | 2 | Aug 12, 2025 | |
| ZLAB Zai Lab | Maintains: Buy | $66 → $69 | $35.73 | +93.12% | 9 | Aug 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $9 → $7 | $1.73 | +304.62% | 10 | Aug 11, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $19 → $22 | $14.36 | +53.20% | 17 | Aug 11, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $1.2 → $1.9 | $1.24 | +53.23% | 12 | Aug 7, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $46 → $51 | $15.74 | +224.02% | 9 | Aug 5, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $176 → $166 | $150.27 | +10.47% | 6 | Aug 5, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $46 → $52 | $27.75 | +87.39% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $37.85 | +37.38% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $21.81 | -67.90% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.36 | +281.36% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.11 | +129.13% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $7.09 | +33.99% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $5.97 | +67.50% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $23 → $35 | $26.69 | +31.14% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $39.51 | +39.21% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $6.09 | +310.51% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $59.73 | +37.28% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $11.09 | +197.57% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $67.25 | +44.24% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.48 | +1,569.80% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $1.98 | +203.03% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $16.82 | +60.52% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.00 | +100.00% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $24.33 | +138.39% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.59 | +783.28% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.97 | +23.71% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $10.39 | +265.74% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $9.66 | +44.93% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.05 | -2.44% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.39 | +48.42% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $3.26 | -69.33% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $12.29 | +184.78% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $29.69 | +347.96% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $2.85 | +461.40% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.09 | +817.43% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.11 | +468.24% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.73 | - | 14 | Sep 28, 2021 |
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $19.53
Upside: +68.97%
Arcturus Therapeutics Holdings
Aug 12, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $19.48
Upside: +151.54%
Olema Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $20 → $21
Current: $5.51
Upside: +281.13%
Zai Lab
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $35.73
Upside: +93.12%
Biomea Fusion
Aug 11, 2025
Maintains: Buy
Price Target: $9 → $7
Current: $1.73
Upside: +304.62%
Zymeworks
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $14.36
Upside: +53.20%
Lexicon Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.24
Upside: +53.23%
Syndax Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $15.74
Upside: +224.02%
Krystal Biotech
Aug 5, 2025
Maintains: Neutral
Price Target: $176 → $166
Current: $150.27
Upside: +10.47%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $46 → $52
Current: $27.75
Upside: +87.39%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $37.85
Upside: +37.38%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $21.81
Upside: -67.90%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.36
Upside: +281.36%
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $6.11
Upside: +129.13%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.09
Upside: +33.99%
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.97
Upside: +67.50%
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $26.69
Upside: +31.14%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $39.51
Upside: +39.21%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $6.09
Upside: +310.51%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $59.73
Upside: +37.28%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $11.09
Upside: +197.57%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $67.25
Upside: +44.24%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.48
Upside: +1,569.80%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.98
Upside: +203.03%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $16.82
Upside: +60.52%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.00
Upside: +100.00%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $24.33
Upside: +138.39%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.59
Upside: +783.28%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.97
Upside: +23.71%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $10.39
Upside: +265.74%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $9.66
Upside: +44.93%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.05
Upside: -2.44%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.39
Upside: +48.42%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $3.26
Upside: -69.33%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $12.29
Upside: +184.78%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $29.69
Upside: +347.96%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $2.85
Upside: +461.40%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.09
Upside: +817.43%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.11
Upside: +468.24%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.73
Upside: -